| |
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | ABEO  | Abeona Therapeutics Inc | $209.7M | NASDAQ | 6.9963 |
| ACAD | ACADIA Pharmaceuticals Inc. | $3.5B | NASDAQ | 47.5495 |
| ADMS | Adamas Pharmaceuticals Inc | $351.8M | NASDAQ | 20.2166 |
| ADXS | Advaxis, Inc. | $287.5M | NASDAQ | 2.7094 |
| AEZS | AEterna Zentaris Inc. (USA) | $11.6M | NASDAQ | -12.1758 |
| AGEN | Agenus Inc | $321.0M | NASDAQ | -6.5633 |
| AMRI | Albany Molecular Research, Inc. | $740.8M | NASDAQ | 1.1789 |
| ALKS | Alkermes Plc | $8.8B | NASDAQ | 10.3036 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $4.9B | NASDAQ | 7.2451 |
| ANIP | ANI Pharmaceuticals Inc | $569.3M | NASDAQ | 2.8751 |
| ANIK | Anika Therapeutics Inc | $679.7M | NASDAQ | 25.5586 |
| APTO | Aptose Biosciences Inc | $18.1M | NASDAQ | -22.2143 |
| ABUS | Arbutus Biopharma Corp | $183.6M | NASDAQ | -1.2573 |
| ARNA | Arena Pharmaceuticals, Inc. | $291.9M | NASDAQ | -9.1061 |
| ARQL | ArQule, Inc. | $71.8M | NASDAQ | -15.8684 |
| AST | Asterias Biotherapeutics Inc | $165.8M | NYSE MKT | 4.0406 |
| LIFE | aTyr Pharma Inc | $77.1M | NASDAQ | -0.1578 |
| BNTC | Benitec Biopharma Ltd (ADR) | $25.6M | NASDAQ | |
| BPTH | Bio-Path Holdings Inc | $51.6M | NASDAQ | 5.0838 |
| TECH | BIO-TECHNE Corp | $4.1B | NASDAQ | 11.4784 |
| BASI | Bioanalytical Systems, Inc. | $12.8M | NASDAQ | -0.089 |
| BLRX | Bioline RX Ltd | $48.0M | NASDAQ | |
| BVXV | BiondVax Pharmaceuticals Ltd (ADR) | $30.8M | NASDAQ | |
| BPMC | Blueprint Medicines Corp | $1.1B | NASDAQ | 9.4114 |
| BCLI | Brainstorm Cell Therapeutics Inc | $75.0M | NASDAQ | 43.6072 |
| BUR | Burcon Nutrascience Corporation | $36.9M | NASDAQ | |
| CLBS | Caladrius Biosciences Inc | $29.4M | NASDAQ | -9.7647 |
| CARA | Cara Therapeutics Inc | $468.7M | NASDAQ | 18.8488 |
| CDNA | CareDx Inc | $68.7M | NASDAQ | -1.7557 |
| CASI | CASI Pharmaceuticals Inc | $48.9M | NASDAQ | -16.9615 |
| CLDX | Celldex Therapeutics, Inc. | $316.7M | NASDAQ | -0.4966 |
| CLLS | Cellectis SA (ADR) | $852.2M | NASDAQ | 9.3079 |
| CYAD | Celyad SA (ADR) | $397.0M | NASDAQ | |
| CERC | Cerecor Inc | $11.3M | NASDAQ | -15.3009 |
| CSBR | Champions Oncology Inc | $27.4M | NASDAQ | -10.4479 |
| CRL | Charles River Laboratories Intl. Inc | $4.2B | NYSE | 2.1356 |
| CPHI | China Pharma Holdings, Inc. | $9.6M | NYSE MKT | 1.0397 |
| CDXC | Chromadex Corp | $131.4M | NASDAQ | 6.6154 |
| CBLI | Cleveland BioLabs, Inc. | $38.1M | NASDAQ | -9.3297 |
| CDXS | Codexis, Inc. | $191.5M | NASDAQ | -2.6714 |
| CGEN | Compugen Ltd. (USA) | $214.9M | NASDAQ | 12.5777 |
| CRVS | Corvus Pharmaceuticals Inc | $223.5M | NASDAQ | 18.6832 |
| CTIC | CTI BioPharma Corp | $117.2M | NASDAQ | -44.5896 |
| CRIS | Curis, Inc. | $247.3M | NASDAQ | -15.7359 |
| CYTR | CytRx Corporation | $56.7M | NASDAQ | -7.5922 |
| EDIT | Editas Medicine Inc | $706.2M | NASDAQ | 4.1797 |
| EIGR | Eiger Biopharmaceuticals Inc | $50.0M | NASDAQ | 0.8311 |
| EBS | Emergent Biosolutions Inc | $1.3B | NYSE | 3.4068 |
| ENTA | Enanta Pharmaceuticals Inc | $634.2M | NASDAQ | 34.9617 |
| ESPR | Esperion Therapeutics Inc | $824.8M | NASDAQ | 29.453 |
| EXAS | EXACT Sciences Corporation | $3.6B | NASDAQ | 50.2853 |
| FCSC | Fibrocell Science Inc | $29.4M | NASDAQ | -9.1797 |
| FGEN | FibroGen Inc | $1.7B | NASDAQ | 2.7893 |
| FLML | Flamel Technologies S.A. (ADR) | $428.5M | NASDAQ | 0.6266 |
| FMI | Foundation Medicine Inc | $1.2B | NASDAQ | 13.1495 |
| GLPG | Galapagos NV (ADR) | $3.4B | NASDAQ | |
| GALT | Galectin Therapeutics Inc | $23.7M | NASDAQ | 4.174 |
| GENE | Genetic Technologies Limited (ADR) | $20.3M | NASDAQ | -1.2168 |
| GNCA | Genocea Biosciences Inc | $155.8M | NASDAQ | 3.1463 |
| GHDX | Genomic Health, Inc. | $1.0B | NASDAQ | 14.2066 |
| GNVC | GenVec Inc | $16.2M | NASDAQ | -48.5986 |
| GBT | Global Blood Therapeutics Inc | $1.2B | NASDAQ | 44.9045 |
| GTXI | GTx, Inc. | $68.3M | NASDAQ | -20.5018 |
| HRTX | Heron Therapeutics Inc | $570.1M | NASDAQ | -7.8667 |
| ICLR | ICON PLC | $4.8B | NASDAQ | 4.9497 |
| IDRA | Idera Pharmaceuticals Inc | $220.9M | NASDAQ | 7.9772 |
| ICCC | ImmuCell Corporation | $25.6M | NASDAQ | 4.1266 |
| IMUC | ImmunoCellular Therapeutics Ltd | $5.3M | NYSE MKT | -6.9581 |
| IMGN | ImmunoGen, Inc. | $357.0M | NASDAQ | -5.1217 |
| IMMU | Immunomedics, Inc. | $756.4M | NASDAQ | -4.2227 |
| INCR | INC Research Holdings Inc | $3.0B | NASDAQ | 2.8513 |
| INCY | Incyte Corporation | $21.7B | NASDAQ | 10.4229 |
| INFI | Infinity Pharmaceuticals Inc. | $84.8M | NASDAQ | -4.9028 |
| INO | Inovio Pharmaceuticals Inc | $525.1M | NASDAQ | 3.503 |
| NTLA | Intellia Therapeutics Inc | $528.5M | NASDAQ | 4.3671 |
| XON | Intrexon Corp | $2.9B | NYSE | 3.81 |
| NVTA | InVitae Corp | $267.8M | NYSE | 8.1936 |
| IONS | Ionis Pharmaceuticals Inc | $5.7B | NASDAQ | 3.6388 |
| IRWD | Ironwood Pharmaceuticals, Inc. | $2.4B | NASDAQ | 0.7201 |
| ISR | IsoRay, Inc. | $30.8M | NYSE MKT | 6.8239 |
| JAGX | Jaguar Animal Health Inc | $10.9M | NASDAQ | -15.3255 |
| LGND | Ligand Pharmaceuticals Inc. | $2.4B | NASDAQ | 4.4765 |
| LBIO | Lion Biotechnologies Inc | $350.6M | NASDAQ | 42.1998 |
| MATN | Mateon Therapeutics Inc | $17.2M | NASDAQ | -20.1407 |
| MEDP | Medpace Holdings Inc | $1.0B | NASDAQ | 2.073 |
| MACK | Merrimack Pharmaceuticals Inc | $487.2M | NASDAQ | -14.227 |
| MESO | Mesoblast limited (ADR) | $744.9M | NASDAQ | 2.6176 |
| MNTA | Momenta Pharmaceuticals, Inc. | $1.1B | NASDAQ | 6.034 |
| NAVB | Navidea Biopharmaceuticals Inc | $74.5M | NYSE MKT | -47.7514 |
| NKTR | Nektar Therapeutics | $3.1B | NASDAQ | -0.1225 |
| NEPT | Neptune Technologies & Bioressources-Ord | $76.4M | NASDAQ | |
| NLNK | NewLink Genetics Corp | $504.6M | NASDAQ | 6.4564 |
| NBY | NovaBay Pharmaceuticals, Inc. | $34.2M | NYSE MKT | -5.4006 |
| NVAX | Novavax, Inc. | $271.2M | NASDAQ | -2.1826 |
| NVGN | Novogen Limited (ADR) | $17.5M | NASDAQ | 1.4406 |
| NVTR | Nuvectra Corp | $88.9M | NASDAQ | 2.0192 |
| OHRP | OHR Pharmaceutical Inc | $20.5M | NASDAQ | 18.2564 |
| OGXI | OncoGenex Pharmaceuticals Inc | $10.8M | NASDAQ | -8.2854 |
| OMED | Oncomed Pharmaceuticals Inc | $131.3M | NASDAQ | -1.6486 |
| ONCS | OncoSec Medical Inc | $19.8M | NASDAQ | 1.0515 |
| OPGN | OpGen Inc | $17.4M | NASDAQ | -18.4904 |
| ORMP | Oramed Pharmaceuticals, Inc. | $108.8M | NASDAQ | 3.2057 |
| ONVO | Organovo Holdings Inc | $261.3M | NASDAQ | 20.04 |
| OVAS | OvaScience Inc | $49.5M | NASDAQ | 0.2332 |
| PTN | Palatin Technologies, Inc. | $62.7M | NYSE MKT | -43.2988 |
| PRXL | PAREXEL International Corporation | $4.1B | NASDAQ | 3.6623 |
| PDLI | PDL BioPharma Inc | $379.1M | NASDAQ | 1.9406 |
| PSTI | Pluristem Therapeutics Inc. | $109.0M | NASDAQ | 4.3069 |
| PTLA | Portola Pharmaceuticals Inc | $2.3B | NASDAQ | 6.4895 |
| PRAH | PRA Health Sciences Inc | $4.2B | NASDAQ | 2.6421 |
| PRAN | Prana Biotechnology Limited (ADR) | $21.0M | NASDAQ | 1.6648 |
| PBMD | Prima BioMed Ltd (ADR) | $50.0M | NASDAQ | |
| PTGX | Protagonist Therapeutics Inc | $170.5M | NASDAQ | 15.9321 |
| PLX | Protalix Biotherapeutics Inc | $84.9M | NYSE MKT | -1.6711 |
| PBYI | Puma Biotechnology Inc | $1.2B | NYSE | 13.114 |
| QGEN | Qiagen NV | $7.5B | NASDAQ | 3.5735 |
| QLTI | QLT Inc. (USA) | $103.0M | NASDAQ | -1.3847 |
| Q | Quintiles Transnational Holdings Inc | $9.8B | NYSE | 0.7991 |
| RDHL | RedHill Biopharma Ltd - ADR | $124.5M | NASDAQ | |
| RGLS | Regulus Therapeutics Inc | $76.7M | NASDAQ | -1.8794 |
| RPRX | Repros Therapeutics Inc | $20.4M | NASDAQ | -45.6262 |
| ROKA | Roka Bioscience Inc | $6.0M | NASDAQ | -4.2753 |
| ROSG | Rosetta Genomics Ltd. (USA) | $44.2M | NASDAQ | -13.462 |
| RXII | RXi Pharmaceuticals Corp | $3.6M | NASDAQ | -5.1099 |
| SAGE | SAGE Therapeutics Inc | $2.3B | NASDAQ | 37.9866 |
| SGEN | Seattle Genetics, Inc. | $8.9B | NASDAQ | 25.5943 |
| SNMX | Senomyx Inc. | $42.3M | NASDAQ | -11.8247 |
| SENS | Senseonics Holdings Inc | $136.3M | NYSE MKT | -9.3134 |
| SPPI | Spectrum Pharmaceuticals, Inc. | $483.7M | NASDAQ | 0.9523 |
| SBOT | Stellar Biotechnologies Inc | $13.3M | NASDAQ | 9.6468 |
| SNSS | Sunesis Pharmaceuticals, Inc. | $45.4M | NASDAQ | -17.1663 |
| TENX | Tenax Therapeutics Inc | $13.4M | NASDAQ | -10.5963 |
| TGTX | TG Therapeutics Inc | $784.7M | NASDAQ | 19.6024 |
| THLD | Threshold Pharmaceuticals, Inc. | $35.8M | NASDAQ | -14.4295 |
| UTHR | United Therapeutics Corporation | $5.4B | NASDAQ | 9.6422 |
| VCYT | Veracyte Inc | $225.4M | NASDAQ | 2.1423 |
| VRML | Vermillion, Inc. | $100.8M | NASDAQ | -52.2533 |
| VYGR | Voyager Therapeutics Inc | $250.5M | NASDAQ | 3.2554 |
| WVE | Wave Life Sciences Ltd | $520.1M | NASDAQ | 14.3992 |
| XTLB | X T L Biopharmaceuticals Ltd (ADR) | $12.7M | NASDAQ | -22.0037 |
| MBLX | Yield10 Bioscience Inc | $10.5M | NASDAQ | -41.2998 |
| ZGNX | Zogenix, Inc. | $314.8M | NASDAQ | -0.3472 |
| ZYNE | Zynerba Pharmaceuticals Inc | $180.3M | NASDAQ | 14.7285 |
= link to the company website, 
